インテリジェントコンプライアンス：AIで臨床試験開示を変革

Why Disclosure Matters Now: Presenting the Citeline Maturity Model for Clinical Trial Transparency

A comprehensive maturity model for clinical trial disclosure and transparency is a strategic assessment tool for biopharmaceutical companies.

The Hidden Implications of Clinical Trial Disclosure Noncompliance

Potential fallout from clinical trial disclosure noncompliance goes beyond regulatory penalties; adherence has improved but less so for smaller companies.

Clinical Data Transparency a Big Challenge for Smaller Sponsors

Many smaller organizations have not yet implemented a specialized clinical trial disclosure system. Robust transparency, and perhaps even just compliance with multiple regulators, requires commitment from the C-suite for companies of all sizes.